Cargando…
The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study
BACKGROUND: Immunotherapeutic treatments targeting amyloid-β plaques in Alzheimer’s disease (AD) are associated with the presence of amyloid-related imaging abnormalities with oedema or effusion (ARIA-E), whose detection and classification is crucial to evaluate subjects enrolled in clinical trials....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811582/ https://www.ncbi.nlm.nih.gov/pubmed/28956123 http://dx.doi.org/10.1007/s00330-017-5022-6 |
_version_ | 1783299889852055552 |
---|---|
author | Martens, Roland M. Bechten, Arianne Ingala, Silvia van Schijndel, Ronald A. Machado, Vania B. de Jong, Marcus C. Sanchez, Esther Purcell, Derk Arrighi, Michael H. Brashear, Robert H. Wattjes, Mike P. Barkhof, Frederik |
author_facet | Martens, Roland M. Bechten, Arianne Ingala, Silvia van Schijndel, Ronald A. Machado, Vania B. de Jong, Marcus C. Sanchez, Esther Purcell, Derk Arrighi, Michael H. Brashear, Robert H. Wattjes, Mike P. Barkhof, Frederik |
author_sort | Martens, Roland M. |
collection | PubMed |
description | BACKGROUND: Immunotherapeutic treatments targeting amyloid-β plaques in Alzheimer’s disease (AD) are associated with the presence of amyloid-related imaging abnormalities with oedema or effusion (ARIA-E), whose detection and classification is crucial to evaluate subjects enrolled in clinical trials. PURPOSE: To investigate the applicability of subtraction MRI in the ARIA-E detection using an established ARIA-E-rating scale. METHODS: We included 75 AD patients receiving bapineuzumab treatment, including 29 ARIA-E cases. Five neuroradiologists rated their brain MRI-scans with and without subtraction images. The accuracy of evaluating the presence of ARIA-E, intraclass correlation coefficient (ICC) and specific agreement was calculated. RESULTS: Subtraction resulted in higher sensitivity (0.966) and lower specificity (0.970) than native images (0.959, 0.991, respectively). Individual rater detection was excellent. ICC scores ranged from excellent to good, except for gyral swelling (moderate). Excellent negative and good positive specific agreement among all ARIA-E imaging features was reported in both groups. Combining sulcal hyperintensity and gyral swelling significantly increased positive agreement for subtraction images. CONCLUSION: Subtraction MRI has potential as a visual aid increasing the sensitivity of ARIA-E assessment. However, in order to improve its usefulness isotropic acquisition and enhanced training are required. The ARIA-E rating scale may benefit from combining sulcal hyperintensity and swelling. KEY POINTS: • Subtraction technique can improve detection amyloid-related imaging-abnormalities with edema/effusion in Alzheimer’s patients. • The value of ARIA-E detection, classification and monitoring using subtraction was assessed. • Validation of an established ARIA-E rating scale, recommendations for improvement are reported. • Complementary statistical methods were employed to measure accuracy, inter-rater-reliability and specific agreement. |
format | Online Article Text |
id | pubmed-5811582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-58115822018-02-23 The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study Martens, Roland M. Bechten, Arianne Ingala, Silvia van Schijndel, Ronald A. Machado, Vania B. de Jong, Marcus C. Sanchez, Esther Purcell, Derk Arrighi, Michael H. Brashear, Robert H. Wattjes, Mike P. Barkhof, Frederik Eur Radiol Neuro BACKGROUND: Immunotherapeutic treatments targeting amyloid-β plaques in Alzheimer’s disease (AD) are associated with the presence of amyloid-related imaging abnormalities with oedema or effusion (ARIA-E), whose detection and classification is crucial to evaluate subjects enrolled in clinical trials. PURPOSE: To investigate the applicability of subtraction MRI in the ARIA-E detection using an established ARIA-E-rating scale. METHODS: We included 75 AD patients receiving bapineuzumab treatment, including 29 ARIA-E cases. Five neuroradiologists rated their brain MRI-scans with and without subtraction images. The accuracy of evaluating the presence of ARIA-E, intraclass correlation coefficient (ICC) and specific agreement was calculated. RESULTS: Subtraction resulted in higher sensitivity (0.966) and lower specificity (0.970) than native images (0.959, 0.991, respectively). Individual rater detection was excellent. ICC scores ranged from excellent to good, except for gyral swelling (moderate). Excellent negative and good positive specific agreement among all ARIA-E imaging features was reported in both groups. Combining sulcal hyperintensity and gyral swelling significantly increased positive agreement for subtraction images. CONCLUSION: Subtraction MRI has potential as a visual aid increasing the sensitivity of ARIA-E assessment. However, in order to improve its usefulness isotropic acquisition and enhanced training are required. The ARIA-E rating scale may benefit from combining sulcal hyperintensity and swelling. KEY POINTS: • Subtraction technique can improve detection amyloid-related imaging-abnormalities with edema/effusion in Alzheimer’s patients. • The value of ARIA-E detection, classification and monitoring using subtraction was assessed. • Validation of an established ARIA-E rating scale, recommendations for improvement are reported. • Complementary statistical methods were employed to measure accuracy, inter-rater-reliability and specific agreement. Springer Berlin Heidelberg 2017-09-27 2018 /pmc/articles/PMC5811582/ /pubmed/28956123 http://dx.doi.org/10.1007/s00330-017-5022-6 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Neuro Martens, Roland M. Bechten, Arianne Ingala, Silvia van Schijndel, Ronald A. Machado, Vania B. de Jong, Marcus C. Sanchez, Esther Purcell, Derk Arrighi, Michael H. Brashear, Robert H. Wattjes, Mike P. Barkhof, Frederik The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study |
title | The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study |
title_full | The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study |
title_fullStr | The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study |
title_full_unstemmed | The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study |
title_short | The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study |
title_sort | value of subtraction mri in detection of amyloid-related imaging abnormalities with oedema or effusion in alzheimer’s patients: an interobserver study |
topic | Neuro |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811582/ https://www.ncbi.nlm.nih.gov/pubmed/28956123 http://dx.doi.org/10.1007/s00330-017-5022-6 |
work_keys_str_mv | AT martensrolandm thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT bechtenarianne thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT ingalasilvia thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT vanschijndelronalda thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT machadovaniab thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT dejongmarcusc thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT sanchezesther thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT purcellderk thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT arrighimichaelh thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT brashearroberth thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT wattjesmikep thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT barkhoffrederik thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT martensrolandm valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT bechtenarianne valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT ingalasilvia valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT vanschijndelronalda valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT machadovaniab valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT dejongmarcusc valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT sanchezesther valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT purcellderk valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT arrighimichaelh valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT brashearroberth valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT wattjesmikep valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy AT barkhoffrederik valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy |